120
Views
1
CrossRef citations to date
0
Altmetric
Articles

Applying whole exome sequencing in a consanguineous population with autism spectrum disorder

, , , , , , , , , , , & show all
Pages 190-200 | Received 29 Nov 2020, Accepted 27 May 2021, Published online: 21 Jun 2021

References

  • Al-Amri, A., Al Saegh, A., Al-Mamari, W., El-Asrag, M. E., Ivorra, J. L., Cardno, A. G., Inglehearn, C. F., Clapcote, S. J., and Ali, M. 2016. Homozygous single base deletion in TUSC3 causes intellectual disability with developmental delay in an Omani family. American Journal of Medical Genetics, Part A, 170, 1826–1831.
  • Al-Futaisi, A., Idris, A., Al-Sayegh, A. and Al-Mamari, W. 2016. Coexistence of autism spectrum disorders among three children with tuberous sclerosis complex: Case reports and review of literature. Sultan Qaboos University Medical Journal, 16, e520–524.
  • Al-Mamari, W., Al-Saegh, A., Al-Kindy, A., Bruwer, Z., Al-Murshedi, F. and Al-Thihli, K. 2015. Diagnostic Yield of Chromosomal Microarray Analysis in a Cohort of Patients with Autism Spectrum Disorders from a Highly Consanguineous Population. Journal of Autism and Developmental Disorders. Springer US, 45, 2323–2328.
  • Al-Mamri, W., et al. 2019. Revisiting the prevalence of autism spectrum disorder among omani children a multicentre study. Sultan Qaboos University Medical Journal, 19, e305–e309.
  • American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders (DSM-5®). 5th ed. Washington: American Psychiatric Association.
  • Anello, A., Reichenberg, A., Luo, X., Schmeidler, J., Hollander, E., Smith, C. J., Puleo, C. M., Kryzak, L. A. and Silverman, J. M. 2009. Brief report: Parental age and the sex ratio in autism. Journal of Autism and Developmental Disorders, 39, 1487–1492.
  • Bernier, R., Aaronson, B. and McPartland, J. 2013. The role of imitation in the observed heterogeneity in EEG mu rhythm in autism and typical development. Brain and Cognition, 82, 69–75.
  • Bittles, A. H. 2001. Consanguinity and its relevance to clinical genetics. Clinical Genetics, 60, 89–98.
  • Bosl, W., et al. 2011. EEG complexity as a biomarker for autism spectrum disorder risk. BMC Medicine. BioMed Central, 9, 18.
  • Bozzi, Y., Provenzano, G. and Casarosa, S. 2018. Neurobiological bases of autism–epilepsy comorbidity: A focus on excitation/inhibition imbalance. European Journal of Neuroscience, 47, 534–548.
  • Casanova, E. L., Baeza-Velasco, C., Buchanan, C. B. and Casanova, M. F. 2020. The relationship between autism and ehlers-danlos syndromes/hypermobility spectrum disorders. Journal of Personalized Medicine. 260.
  • Chérot, E., et al. 2018. Using medical exome sequencing to identify the causes of neurodevelopmental disorders: Experience of 2 clinical units and 216 patients. Clinical Genetics, 93(3), 567–576.
  • Doan, R. N., Lim, E. T., De Rubeis, S., Betancur, C., Cutler, D. J., Chiocchetti, A. G., Overman, L. M., Soucy, A., Goetze, S., Freitag, C. M., Daly, M. J., Walsh, C. A., Buxbaum, J. D. and Yu, T. W. 2019. Recessive gene disruptions in autism spectrum disorder. Nature Genetics, 51, 1092–1098.
  • Dragojlovic, N., et al. 2018. The cost and diagnostic yield of exome sequencing for children with suspected genetic disorders: A benchmarking study. Genetics in Medicine. 20, 1013–1021.
  • Du, X., Gao, X., Liu, X., Shen, L., Wang, K., Fan, Y., Sun, Y., Luo, X., Liu, H., Wang, L., Wang, Y., Gong, Z., Wang, J., Yu, Y. and Li, F. 2018. Genetic diagnostic evaluation of trio-based whole exome sequencing among children with diagnosed or suspected autism spectrum disorder. Frontiers in Genetics, 9, 594.
  • Durkin, M. S., Elsabbagh, M., Barbaro, J., Gladstone, M., Happe, F., Hoekstra, R. A., Lee, L.-C., Rattazzi, A., Stapel-Wax, J., Stone, W. L., Tager-Flusberg, H., Thurm, A., Tomlinson, M., and Shih, A. 2015. Autism screening and diagnosis in low resource settings: Challenges and opportunities to enhance research and services worldwide. Autism Research, 8(5), 473–476.
  • Elsabbagh, M., Divan, G., Koh, Y.-J., Kim, Y. S., Kauchali, S., Marcín, C., Montiel-Nava, C., Patel, V., Paula, C. S., Wang, C., Yasamy, M. T. and Fombonne, E. 2012. Global prevalence of autism and other pervasive developmental disorders. Autism Research, 5, 160–179.
  • Fernandez, B. A. and Scherer, S. W. 2017. Syndromic autism spectrum disorders: Moving from a clinically defined to a molecularly defined approach. Dialogues in Clinical Neuroscience. Les Laboratoires Seriver, 19, 353–371.
  • Geschwind, D. H. and Flint, J. 2015. Genetics and genomics of psychiatric disease. Science, 349, 1489–1494.
  • Geschwind, D. H. and State, M. W. 2015. Gene hunting in autism spectrum disorder: On the path to precision medicine. The Lancet Neurology, 14, 1109–1120.
  • Guisso, D. R., Saadeh, F. S., Saab, D., El Deek, J., Chamseddine, S., Abou-El-Hassan, H., Majari, G. and Boustany, R.-M. 2018. Association of autism with maternal infections, perinatal and other risk factors: A case-control study. Journal of Autism and Developmental Disorders, 48, 2022–2022.
  • Halladay, A. K., Bishop, S., Constantino, J. N., Daniels, A. M., Koenig, K., Palmer, K., Messinger, D., Pelphrey, K., Sanders, S. J., Singer, A. T., Taylor, J. L. and Szatmari, P. 2015. Sex and gender differences in autism spectrum disorder: Summarizing evidence gaps and identifying emerging areas of priority. Molecular Autism, 6, 1–5.
  • Harris, H. K., Sideridis, G. D., Barbaresi, W. J. and Harstad, E. 2020. Pathogenic yield of genetic testing in autism spectrum disorder. Pediatrics, 146, e20193211.
  • Iossifov, I., et al. 2014. The contribution of de novo coding mutations to autism spectrum disorder. Nature. Nature, 515, 216–221.
  • Islam, M. M. 2012. The practice of consanguineous marriage in Oman: Prevalence, trends and determinants. Journal of Biosocial Science, 44, 571–594.
  • Kawarai, T., et al. 2016. A homozygous mutation of VWA3B causes cerebellar ataxia with intellectual disability. Journal of Neurology, Neurosurgery and Psychiatry, 87, 656–662.
  • Kim, Y. S. and Leventhal, B. L. 2015. Genetic epidemiology and insights into interactive genetic and environmental effects in autism spectrum disorders. Biological Psychiatry, 77, 66–74.
  • Ku, C. S., Naidoo, N. and Pawitan, Y. 2011. Revisiting Mendelian disorders through exome sequencing. Human Genetics, 129, 351–370.
  • Lee, B. K. and McGrath, J. J. 2015. Advancing parental age and autism: Multifactorial pathways. Trends in Molecular Medicine, 21, 118–125.
  • Lewis, M. L., Kesler, M., Candy, S. A., Rho, J. M., and Pittman, Q. J. 2018. Comorbid epilepsy in autism spectrum disorder: Implications of postnatal inflammation for brain excitability. Epilepsia, 59, 1316–1326.
  • Maenner, M. J., et al. 2020. Prevalence of autism spectrum disorder among children aged 8 years — autism and developmental disabilities monitoring network, 11 Sites, United States, 2016. MMWR. Surveillance Summaries, 69, 1–12.
  • Mamidala, M. P., Kalikiri, M. K., Praveen Kumar, P. T. V., Rajesh, N., Vallamkonda, O. R. and Rajesh, V. 2015. Consanguinity in India and Its association with autism spectrum disorder. Autism Research, 8, 224–228.
  • Miles, J.H., Takahashi, T.N., Bagby, S., Sahota, P.K., Vaslow, D.F., Wang, C.H., Hillman, R.E. and Farmer, J.E. 2005. Essential versus complex autism: Definition of fundamental prognostic subtypes. American Journal of Medical Genetics Part A, John Wiley & Sons, Ltd, 135A, 171–180.
  • MindSpec. 2021. AutDB. Available at: <http://autism.mindspec.org/autdb/Welcome.do> [Accessed 26 February 2021].
  • National Centre of Statistics and Information. 2014. Population, Statistical Year Book. Available at: http://www.ncsi.gov.om/NCSI_website/book/SYB2014/contents.htm.
  • Richards, C. S., Bale, S., Bellissimo, D. B., Das, S., Grody, W. W., Hegde, M. R., Lyon, E. and Ward, B. E. 2008. ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. Genetics in Medicine, 10Genet Med, 294–300.
  • Richards, S., et al. 2015. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17, 405–424.
  • Rivard, M., et al. 2014. Indicators of intellectual disabilities in young children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 45, 127–137.
  • Rossi, M., El-Khechen, D., Black, M. H., Farwell Hagman, K. D., Tang, S. and Powis, Z. 2017. Outcomes of diagnostic exome sequencing in patients with diagnosed or suspected autism spectrum disorders. Pediatric Neurology, 70, 34–43.e2.
  • Sandin, S., et al. 2017. The Heritability of Autism Spectrum Disorder. JAMA, 318, 1182–1184.
  • Schaefer, G. B. and Mendelsohn, N. J. 2013. Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genetics in Medicine, 15, 399–407.
  • Schneeberger, P. E., Bierhals, T., Neu, A., Hempel, M. and Kutsche, K. 2019. de novo MEPCE nonsense variant associated with a neurodevelopmental disorder causes disintegration of 7SK snRNP and enhanced RNA polymerase II activation. Scientific Reports, 9, 12516.
  • Shillington, A. and Capal, J. K. 2021. Genetic testing in patients with nonsyndromic autism spectrum disorder and EEG abnormalities with or without epilepsy: Is exome trio-based testing the best clinical approach? Epilepsy and Behavior, 114, 107564.
  • Srivastava, S., et al. 2019. Meta-analysis and multidisciplinary consensus statement: Exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders and the NDD Exome Scoping Review Work Group. Genetics in Medicine, 21, 2413–2421.
  • Stefanski, A., Calle‐López, Y., Leu, C., Pérez‐Palma, E., Pestana‐Knight, E. and Lal, D. 2021. Clinical sequencing yield in epilepsy, autism spectrum disorder, and intellectual disability: A systematic review and meta-analysis. Epilepsia, 62, 143–151.
  • Stephen, J., et al. 2018. Bi-allelic TMEM94 truncating variants are associated with neurodevelopmental delay, congenital heart defects, and distinct facial dysmorphism. American Journal of Human Genetics, 103, 948–967.
  • Tammimies, K., Marshall, C. R., Walker, S., Kaur, G., Thiruvahindrapuram, B., Lionel, A. C., Yuen, R. K. C., Uddin, M., Roberts, W., Weksberg, R., Woodbury-Smith, M., Zwaigenbaum, L., Anagnostou, E., Wang, Z., Wei, J., Howe, J. L., Gazzellone, M. J., Lau, L., Sung, W. W. L., Whitten, K., Vardy, C., Crosbie, V., Tsang, B., D’Abate, L., Tong, W. W. L., Luscombe, S., Doyle, T., Carter, M. T., Szatmari, P., Stuckless, S., Merico, D., Stavropoulos, D. J., Scherer, S. W. and Fernandez, B. A. 2015. Molecular diagnostic yield of chromosomal microarray analysis and whole-exome sequencing in children with autism spectrum disorder. JAMA , 314, 895–903.
  • The Simons Foundation. 2021. SFARI Gene. Available at: <//gene.sfari.org/> [Accessed: 26 February 2021].
  • Voigt, R. G. and Macias, M. M. 2018. AAP developmental and behavioral pediatrics. 2nd ed. Illinois: American Academy of Pediatrics.
  • Yu, T. W., et al. 2013. Using whole-exome sequencing to identify inherited causes of autism. Neuron, 77, 259–273.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.